97296 ⎘
Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
#5402Method for cloning cognate antibodies
#5403Compositions and methods for the diagnosis and treatment of tumor
#5404TES7 and antibodies that bind thereto
#5405AMPHIREGULIN ANTIBODIES AND THEIR USE TO TREAT CANCER AND PSORIASIS
#5406ANTI-VEGF ANTIBODIES
#5407COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#5408COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#5409Compositions and methods for the therapy and diagnosis of prostate cancer
#5410THERAPEUTIC USE OF ANTI-TF-ANTIGEN ANTIBODY
#5411BREAST CANCER ERADICATION PROGRAM
#5412Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
#5413COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#5414Human anti-CD100 antibodies
#5415Cytotoxicity mediation of cells evidencing surface expression of CD44
#5416Antibody-avidin fusion proteins as cytotoxic drugs
#5417Treatment of rheumatoid arthritis with galectin-3 antagonists
#5418Single dose use of CD20-specific binding molecules
#5419Cytotoxicity mediation of cells evidencing surface expression of TROP-2
#5420USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#5421Methods of use of sialoadhesin factor-2 antibodies
#5422USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#5423USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#5424METHOD OF TREATMENT OF TH2-MEDIATED CONDITIONS USING OPTIMIZED ANTI-CD30 ANTIBODIES
#5425Methods of Treating Chronic Inflammatory Diseases Using a GM-CSF Antagonist
#5426Modified Antibodies Recognizing Receptor Trimers or Higher Multimers
#5427Cspcna Isoform Antibodies and Uses Thereof
#5428MN Gene and Protein
#5429Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
#5430NOVEL GLYCOSYLATED PEPTIDE TARGET IN NEOPLASTIC CELLS
#5431OPTIMIZED CD40 ANTIBODIES AND METHODS OF USING THE SAME
#5432Methods of treating systemic lupus erythematosus with an antibody against costimulatory signal transduction molecule ailim
#5433Method for treating multiple myeloma
#5434Preparation of scFv antibody fragments
#5435Human monoclonal antibodies that specifically bind IGF-II
#5436Anti TfR antibody
#5437Anti-human IL-6 antibodies
#5438Compositions and methods for the treatment of immunologic disorders
#5439ANTI-VEGF ANTIBODIES
#5440Anti-human DLL4 antibodies and compositions
#5441Anti-NGF antibodies and methods using same
#5442Antibodies which activate an erythropoietin receptor
#5443Vascular Endothelial Cell Growth Factor Antagonists
#5444Human antibodies to human delta like ligand 4
#5445Single-chain Antibodies Against Human Insulin-Like Growth Factor I Receptor: Expression, Purification, and Effect on Tumor Growth
#5446Method of modulating the activity of functional immune molecules
#5447Apo-2 ligand
#5448Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
#5449Trimeric collagen scaffold antibodies
#5450Anti-DLL4 antibodies and methods using same
#5451Antagonistic anti-hTNFSF13b human antibodies
#5452Compositions Against Cancer Antigen LIV-1 and Uses Thereof
#5453USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#5454Methods for diagnosing and treating CNS disorders by trans-blood-brain barrier delivery of protein compositions
#5455Compositions and methods for diagnosing and treating cancer
#5456Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
#5457METHODS OF TREATING IDIOPATHIC THROMBOCYTOPENIA PURPURA USING A GM-CSF ANTAGONIST
#5458Fusion antibodies that cross the blood-brain barrier in both directions
#5459MATERIALS AND METHODS TO INHIBIT HODGKIN AND REED STERNBERG CELL GROWTH
#5460Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)
#5461Camptothecin-binding moiety conjugates
#5462Genetic products differentially expressed in tumors and the use thereof
#5463Method for treating psoriasis by administering human antibodies specific for Interleukin 15 (IL-15)
#5464Cripto blocking antibodies and uses thereof
#5465Composition and method for modulating dendritic cell-t cell interaction
#5466High affinity human antibodies to human IL-4 receptor
#5467Humanized immunoglobulins
#5468Anti-α9 integrin antibody and the use thereof
#5469OPTIMIZED IGF-1R ANTIBODIES AND METHODS OF USING THE SAME
#5470Genetically encoded multifunctional compositions bidirectionally transported between peripheral blood and the cns
#5471Targeted binding agents directed to uPAR and uses thereof
#5472IL-14α RNA inhibitors and antibodies to IL-14α for treatment of autoimmune diseases and lymphomas
#5473MORAXELLA CATARRHALIS OUTER MEMBRANE PROTEIN-106 POLYPEPTIDE, GENE SEQUENCE AND USES THEREOF
#5474Method for High Throughput Screening for Anitbodies and Proteins Inducing Apoptosis
#5475Immune-derived moieties reactive against lysophosphatidic acid
#5476Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
#5477Immune-Derived Moieties Reactive Against Bioactive Lipids, and Methods of Making and Using Same
#5478Antibodies against insulin-like growth factor I receptor and uses thereof
#5479Method of treating a pathological syndrome and a pharmaceutical agent
#5480Antibodies to non-functional P2Xreceptor
#5481Polypeptide compounds for inhibiting angiogenesis and tumor growth
#5482Antibodies to notch receptors
#5483Cytotoxicity mediation of cells evidencing surface expression of TROP-2
#5484Method of treating rheumatoid arthritis with antibodies to M-CSF
#5485Fragments of antibodies to epidermal growth factor receptor and methods of their use
#5486EXPRESSION OF FUNCTIONAL ANTIBODY FRAGMENTS
#5487Anti-TAT 113 antibodies
#5488Immune regulation
#5489Antibodies directed to HER-3 and uses thereof
#5490Anti-TAT188 antibodies
#5491Conditioned Cell Immunization
#5492Cytotoxicity mediation of cells evidencing surface expression of CD44
#5493Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof
#5494Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
#5495Naturally occuring IgM antibodies that bind lymphocytes
#5496Monoclonal antibody Sc104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
#5497Reagents and treatment methods for autoimmune diseases
#5498Elevated Hedgehog Pathway Activity In Digestive System Tumors, And Methods Of Treating Digestive Sytem Tumors Having Elevated Hedgehog Pathway Activity
#5499Diagnosis and treatment O prostate cancer
#5500Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies
#5501COMPOSITIONS AND METHODS FOR RESTORING SENSITIVITY OF TUMOR CELLS TO ANTITUMOR THERAPY AND INDUCING APOPTOSIS
#5502Anti-ErbB2 antibodies
#5503Naturally occurring IgM antibodies that bind lymphocytes
#5504Hepatocyte growth factor (HGF) binding antibody
#5505Adenocarcinoma specific antibody SAM-6, and uses thereof
#5506Specific binding members for NGF
#5507Humanized anti-CD47 antibody
#5508Transgenic mammals having human Ig loci including plural Vand V regions and antibodies produced therefrom
#5509DR4 antibodies and uses thereof
#5510IL-17 and IL-23 antagonists and methods of using the same
#5511Agents and Methods for Specifically Blocking CD28-Mediated Signaling
#5512Methods of producing 7C10 and 16C10 CD80-specific antibodies
#5513Hedgehog Signaling in Prostate Regeneration Neoplasia and Metastasis
#5514DR4 antibodies and uses thereof
#5515Methods and reagents for detecting bioactive lipids
#5516Cancerous disease modifying antibodies
#5517ANTI-CD20 ANTIBODIES AND METHODS OF USE
#5518Targeted binding agents directed to PDGFR-alpha and uses thereof
#5519Inhibitors of Dkk-1
#5520BINDING MEMBER WHICH BINDS TO BOTH LEWIS-Y AND LEWIS-B HAPTENS, AND ITS USE FOR TREATING CANCER
#5521Anti-IL-6 monoclonal antibodies
#5522Multispecific antibodies
#5523Method for the treatment of automimmune diseases comprising administering rapamycin and IL-10
#5524IL-18 receptor antagonist and pharmaceutical composition containing the antagonist
#5525MONOVALENT ANTIBODY FRAGMENTS USEFUL AS THERAPEUTICS
#5526Methods for inhibiting the activity of the P40 subunit of human IL-12
#5527Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use
#5528Method of treating a pathological syndrome and a pharmaceutical agent
#5529Stabilized polypeptide compositions
#5530Method of treating a pathological syndrome and a pharmaceutical agent
#5531Methods of using death receptor ligands and CD20 antibodies
#5532Hepatocyte growth factor receptor antagonists and uses thereof
#5533Single-Domain Antibody Strengthening Fusion Protein Vh-Ldp-Ae
#5534Hepatocyte growth factor (HGF) binding antibody
#5535Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies
#5536Methods For Altering T Cell Diversity
#5537Polynucleotides encoding soluble zalpha11 cytokine receptors
#5538Soluble CTLA4 mutant molecules
#5539Humanized monoclonal antibody 31.1 as an anticancer agent
#5540Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
#5541ANTI-CD70 ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR THE TREATMENT OF CANCER AND IMMUNE DISORDERS
#5542Method of treating a pathological syndrome and a pharmaceutical agent
#5543Human immunomodulatory monoclonal antibodies for the treatment of cancer
#5544Substance specific to human PD-1
#5545Neoplasm specific antibodies and uses thereof
#5546Method of treating a pathological syndrome and a pharmaceutical agent
#5547HERV-K Antigens, Antibodies, and Methods
#5548Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
#5549Humanized monoclonal antibodies to hepatocyte growth factor
#5550Treating solid tumors with an antibody to hepatocyte growth factor
#5551Individualized anti-cancer antibodies
#5552Individualized anti-cancer antibodies
#5553Peptides and antibodies to MUC 1 proteins
#5554Antibodies against insulin-like growth factor I receptor and uses thereof
#5555Neutralizing human anti-IGFR antibody
#5556COMPOSITIONS AND METHODS FOR MODULATING VASCULAR DEVELOPMENT
#5557Kits for detecting rank nucleic acids
#5558TWEAK receptor agonists as anti-angiogenic agents
#5559Denatured collagen peptides and uses thereof
#5560B7S1: an immune modulator
#5561Treatment of cancer with a novel anti-IL13 monoclonal antibody
#5562Compositions and methods for treating haematological proliferative disorders
#5563Compositions and methods for treating inflammatory lung disease
#5564Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
#5565Anti-IL-6 antibodies, compositions, methods and uses
#5566Antibodies That Immunospecifically Bind to TRAIL Receptors
#5567Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk
#5568Tumour necrosis factor binding ligands
#5569Bioactive lipid derivatives, and methods of making and using same
#5570Cell Death Inducing Agents
#5571COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#5572Methods for decreasing immune response and treating immune conditions
#5573Tumour necrosis factor binding ligands
#5574ANTIBODY VARIANTS
#5575Immunocompetent Cell Activation Inhibitor and Use Thereof
#5576Fibroblast Growth Factor Receptor-1 Inhibitors and Methods of Treatment Thereof
#5577Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis
#5578Adjuvant therapy with the use of anti-glypican 3 antibody
#5579Antibodies to the human prolactin receptor
#5580TREATMENT WITH ANTI-ERBB2 ANTIBODIES
#5581RECOMBINANT TRIPLEX SCAFFOLD-BASED POLYPEPTIDES
#5582Treatment methods using anti-CD22 antibodies
#5583Sialoadhesin factor-2 antibodies
#5584Antibodies to TGF-beta
#5585Human anti-epidermal growth factor receptor antibody
#5586Recombinant Anti-Cd30 Antibodies and Uses Thereof
#5587Methods of using antibodies against human IL-22
#5588Vascular endothelial cell growth factor antagonists and uses thereof
#5589Chimeric and humanised monoclonal antibodies against Interleukin-13
#5590Methods of treating cancer by administering antibodies to CD200
#5591Epithelial cell specific growth factor keratinocyte growth factor (KGF)
#5592VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
#5593Humanized c-Kit antibody
#5594Methods for treating back or neck pain caused by NGF using a therapeutic agent consisting of ReN-1820, ALE-0540 and capsaicin
#5595IL-17A AND IL-17F ANTAGONISTS AND METHODS OF USING THE SAME
#5596Anti-VEGF antibodies
#5597Anti-FGF19 antibodies and methods using same
#5598Agent for inhibiting proliferation of neural stem cells
#5599Methods of Identifying Neoplasm-Specific Antibodies and Uses Thereof
#5600Antibodies against human IL-22 and uses therefor
#5601Anti-IGF-1R antibodies and uses thereof
#5602ANTI-HYPERPROLIFERATIVE THERAPIES TARGETING HDGF
#5603IL-17A and IL-17F Antagonists and Methods of Using the Same
#5604Binding constructs and methods for use thereof
#5605Multicomponent conjugates which bind to target molecules and stimulate T cell lysis
#5606Detection and treatment of cancer
#5607S100 Protein Inhibitors for Treating Leukemia
#5608Method of treating a pathological syndrome and a pharmaceutical agent
#5609NATURAL KILLER CELL COMPOSITIONS AND METHOD FOR PRODUCTION OF THE SAME
#5610METHODS FOR SOLUBLE ZALPHA11 CYTOKINE RECEPTORS
#5611TAT-046 and methods of assessing and treating cancer
#5612Human anti-IL-23 antibodies, compositions, methods and uses
#5613Use of Antagonist Anti-Cd40 Monoclonal Antibodies for Treatment of Multiple Myeloma
#5614Methods For Inducing Autolysis In Infectious Bacteria
#5615Antibodies that bind MMP-14
#5616Calicheamicin Conjugation by Antibody Deglycosylation
#5617Anti-NGF antibodies and methods using same
#5618Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
#5619Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
#5620Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor
#5621COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
#5622Use of antibodies to the gamma 2 chain of laminin 5 to inhibit tumor growth and metastasis
#5623Methods of upmodulating an immune response with non-activating forms of B7-4
#5624Insulin-like growth factor antibodies and uses thereof
#5625ANTI-VEGF ANTIBODIES
#5626Method of treating inflammation using soluble IL-17RCX4
#5627Peptides for stimulating an immune response against melanoma
#5628Passive targeting of cytotoxic agents
#5629CCR3 inhibition for ocular angiogenesis and macular degeneration
#5630TAT-030 and methods of assessing and treating cancer
#5631TAT-031 and methods of assessing and treating cancer
#5632TRAIL receptor-2 polypeptides and antibodies
#5633Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies
#5634Ovr110 antibody compositions and methods of use
#5635Suppression of TNFalpha and IL-12 in therapy
#5636Methods of treating cancer comprising administering an interleukin-6 antibody variable region
#5637Humanized anti-CD3 specific antibodies
#5638Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended
#5639Cell growth inhibitors containing anti-glypican 3 antibody
#5640Alpha-enolase specific antibody and method of use
#5641Bifunctional energy-reversible acyl-compositions
#5642Cytokine zalpha11 ligand fusion proteins
#5643EpA2 monoclonal antibodies and methods of use thereof
#5644OPTIMIZED ANTI-CD30 ANTIBODIES
#5645Method of modulating the activity of functional immune molecules to Her-2
#5646Method of modulating the activity of functional immune molecules to CD52
#5647Method of modulating the activity of functional immune molecules to GM2
#5648Method of modulating the activity of functional immune molecules to CXCR4 protein
#5649Method of modulating the activity of functional immune molecules
#5650Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein
#5651Monoclonal antibodies to hepatocyte growth factor
#5652Pharmacokinetic modulation and compositions for modified FN3 polypeptides
#5653Compositions and methods for the therapy and diagnosis of lung cancer
#5654Antibody molecules having specificity for human IL-6
#5655Effect of BST2 on inflammation
#5656Humanized anti-CD3 specific antibodies
#5657Receptor coupling agents and compositions thereof
#5658Methods of treating diseases with anti-VEGF antibodies
#5659Optimized anti-CD30 antibodies
#5660Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions
#5661Method of treating transplant rejection with an anti-CD40 antibody
#5662Inhibitors of type 2 vascular endothelial growth factor receptors
#5663Anti-VEGF antibodies
#5664Multivalent immunoglobulin-based bioactive assemblies
#5665Aqueous potassium lactate solution
#5666Antibodies to TGF-BETA
#5667Mesothelioma therapeutic agent
#5668Humanized anti-CD3 specific antibodies
#5669Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
#5670Human antibody molecules for IL-13
#5671Methods of treating cancer using IL-21
#5672Use of an active substance binding to CD28 for producing a pharmaceutical composition for the treatment of B-CLL
#5673Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors
#5674Methods and compositions for the treatment of persistent infections
#5675Antibody and antibody fragments for inhibiting the growth of tumors
#5676Compositions and methods for diagnosing and treating cancer
#5677Lymphotoxin-beta, lymphotoxin-beta Complexes, pharmaceutical preparations and therapeutic uses thereof
#5678VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS
#5679Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia
#5680Anti-CD26 antibodies and methods of use thereof
#5681Composition and method for the treatment of cancer and other physiologic conditins based on modulation of the ppar-gamma pathway and her-kinase axis
#5682Ovr115 antibody compositions and methods of use
#5683CYTOKINE ZALPHA11 LIGAND
#5684Methods of therapy for b cell-related cancers
#5685Methods of therapy for solid tumors expressing the cd40 cell-surface antigen
#5686Antibodies against the tenascin major antigens
#5687CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#5688CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#5689Polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
#5690Anti-cmet antibodies
#5691ErbB4 antagonists
#5692Use of agents that modulate the interaction between PD-1 and its ligands in the downmodulation of immune responses
#5693outer membrane protein-106 polypeptide, gene sequence and uses thereof
#5694METHODS OF TREATING CANCER USING IL-21
#5695Methods and compositions for use in treatment of patients with autoantibody positive disease
#5696EphA2 agonistic monoclonal antibodies and methods of use thereof
#5697Antibody targeting osteoclast-associated protein
#5698Recombinant production of mixtures of antibodies
#5699Tumour necrosis factor binding ligands
#5700Method for making humanized antibodies